| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |